Inventor · disambiguated record
Yutaka Kawakami
Also filed as: KAWAKAMI YUTAKA
28 granted patents·22 pending applications·576 citations·filing 1994–2023
96Inventor score
Files withUS HEALTH14UNIV KEIO12INST OF GENE AND BRAIN SCIENCE4SHIN NIPPON BIOMEDICAL LABORATORIES LTD4JSR CORP3
Top patents by PatentIndex Score
50 records- 0197US7749719B2Melanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 2007·Granted Jul 6, 2010·34 cites·6 claims
- 0296US5844075AMelanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 1995·Granted Dec 1, 1998·180 cites·14 claims
- 0395US5994523AMelanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 1998·Granted Nov 30, 1999·130 cites·6 claims
- 0494US11167018B2Compositions and methods for the induction of CD8+ T-cellsUNIV KEIO·Filed 2017·Granted Nov 9, 2021·6 cites·17 claims
- 0594US10695412B2Compositions and methods for the induction of CD8+ T-cellsUNIV KEIO·Filed 2019·Granted Jun 30, 2020·7 cites·20 claims
- 0694US5874560AMelanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 1994·Granted Feb 23, 1999·95 cites·1 claims
- 0793US10576136B2Compositions and methods for the induction of CD8+ T-cellsUNIV KEIO·Filed 2019·Granted Mar 3, 2020·5 cites·29 claims
- 0890US6270778B1Melanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 1999·Granted Aug 7, 2001·48 cites·14 claims
- 0987US7807805B2Melanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 2007·Granted Oct 5, 2010·2 cites·15 claims
- 1087US6537560B1Melanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 1998·Granted Mar 25, 2003·49 cites·3 claims
- 1185US6965017B2Melanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 2001·Granted Nov 15, 2005·6 cites·3 claims
- 1284US7612044B2Melanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 2007·Granted Nov 3, 2009·1 cites·19 claims
- 1381US7232887B2Melanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 2003·Granted Jun 19, 2007·6 cites·15 claims
- 1480US10849862B2Formulation of curcumin and anti-PD-1 antibodyTHERAVALUES CORP·Filed 2015·Granted Dec 1, 2020·3 cites·8 claims
- 1579US7803614B2Melanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 2007·Granted Sep 28, 2010·2 cites·11 claims
- 1678US2024034440A1Compositions and methods for the induction of cd8+ t-cellsUNIV KEIO·Filed 2023·Application pending·0 cites
- 1776US9169324B2Reducer of immunosuppression by tumor cell and antitumor agent using the sameUNIV KEIO·Filed 2012·Granted Oct 27, 2015·2 cites·1 claims
- 1875US7745212B2Melanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 2007·Granted Jun 29, 2010·0 cites·7 claims
- 1972US11633465B2Compositions and methods for the induction of CD8+ T-cellsUNIV KEIO·Filed 2020·Granted Apr 25, 2023·0 cites·14 claims
- 2071US2024100051A1Anti-Tumor Immunotherapy EnhancerTSUKAMOTO NOBUO·Filed 2023·Application pending·0 cites
- 2170US7763586B2Melanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 2007·Granted Jul 27, 2010·0 cites·8 claims
- 2264US2010291677A1Reducer of immunosuppression by tumor cell and antitumor agent using the sameUNIV KEIO·Filed 2008·Application pending·0 cites
- 2363US2022356265A1Anti-glypican-1-immunizing antigen receptorUNIV KEIO·Filed 2022·Application pending·0 cites
- 2460US12137706B2Micro-encapsulated aquaculture feedSHIN NIPPON BIOMEDICAL LABORATORIES LTD·Filed 2020·Granted Nov 12, 2024·0 cites·9 claims
- 2560US11911348B2Therapeutic agent for cancerTHERAVALUES CORP·Filed 2020·Granted Feb 27, 2024·0 cites·4 claims
- 2660US2018000122A1Micro-encapsulated aquaculture feedSHIN NIPPON BIOMEDICAL LABORATORIES LTD·Filed 2016·Application pending·0 cites
- 2759US8273724B2Melanoma antigens and their use in diagnostic and therapeutic methodsKAWAKAMI YUTAKA·Filed 2011·Granted Sep 25, 2012·0 cites·26 claims
- 2858US8030280B2Melanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 2010·Granted Oct 4, 2011·0 cites·14 claims
- 2957US2025122472A1Method for producing gene-modified t cell populationUNIV KEIO·Filed 2022·Application pending·0 cites
- 3056US11752150B2Anti-tumor immunotherapy enhancerTSUKAMOTO NOBUO·Filed 2018·Granted Sep 12, 2023·0 cites·10 claims
- 3155US2020093103A1Breeding water for anguilliformes and method for rearing anguilliformesSHIN NIPPON BIOMEDICAL LABORATORIES LTD·Filed 2017·Application pending·0 cites
- 3254US11370845B2Anti-glypican-1-immunizing antigen receptorUNIV KEIO·Filed 2016·Granted Jun 28, 2022·0 cites·12 claims
- 3352US11723934B2Compositions and methods for the induction of CD8+ T-cellsUNIV KEIO·Filed 2019·Granted Aug 15, 2023·0 cites·17 claims
- 3451US8323659B2Method for diagnosing and/or treating tumorKUDO CHIE·Filed 2009·Granted Dec 4, 2012·0 cites·5 claims
- 3547US2005043512A1Human glioma antigen originating in testisFiled 2002·Application pending·0 cites
- 3646US2020376029A1Medicament for cancer treatmentJSR CORP·Filed 2020·Application pending·0 cites
- 3745US2007243160A1Remedies for nerve damagesINST OF GENE AND BRAIN SCIENCE·Filed 2006·Application pending·0 cites
- 3845US2023204586A1Method for predicting efficacy of treatment of lung cancer patient using immune checkpoint inhibitorJSR CORP·Filed 2021·Application pending·0 cites
- 3945US2004120925A1Remedies for nerve damagesFiled 2002·Application pending·0 cites
- 4043US2020344982A1Fish-breeding enclosureSHIN NIPPON BIOMEDICAL LABORATORIES LTD·Filed 2019·Application pending·0 cites
- 4143US2006105330A1Diagnostics and remedies for malignant brain tumorINST OF GENE AND BRAIN SCIENCE·Filed 2003·Application pending·0 cites
- 4243US2005019918A1Treatment of cancer by inhibiting BRAF expressionFiled 2004·Application pending·0 cites
- 4343US2022373551A1Method for separating and detecting exosomes, and kit for separation and detection thereofJSR CORP·Filed 2020·Application pending·0 cites
- 4438US7384627B2Antitumor agents with the use of HSVINST OF GENE AND BRAIN SCIENCE·Filed 2003·Granted Jun 10, 2008·0 cites·4 claims
- 4536US2019192458A1Therapeutic/prophylactic agent for graft-versus-host disease, fibrocyte invasion inhibitor, and inhibitor against tear reduction and reduction in goblet cellsUNIV KEIO·Filed 2017·Application pending·0 cites
- 4635US2005226852A1Method of inducing growth of nerve stem cellsINST OF GENE AND BRAIN SCIENCE·Filed 2003·Application pending·0 cites
- 4735US2013273653A1Diagnostic marker for melanoma, pharmaceutical composition comprising inhibitor of the function of the histatin-1 protein and immunosuppressorYAGUCHI TOMONORI·Filed 2011·Application pending·0 cites
- 4833US2008167256A1Cancer Therapy Via the Inhibition of Skp-2 ExpressionSUMIMOTO HIDETOSHI·Filed 2005·Application pending·0 cites
- 4931US2004072265A1Human glioma antigen and process for preparing the sameFiled 2001·Application pending·0 cites
- 5027US2013122029A1Cancer vaccineKUDO CHIE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yutaka Kawakami files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →